Clinical trials
Phase 3 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Recruiting | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Celgene | 4 |
| Fred Hutchinson Cancer Center | 3 |
| Incyte Corporation | 3 |
| Sierra Oncology LLC - a GSK company | 3 |
| AbbVie | 2 |
| Alliance for Clinical Trials in Oncology | 2 |
| CTI BioPharma | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 53 |
| Myeloproliferative Disorders | 29 |
| Burkitt Lymphoma | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 21 |
| Leukemia, Myeloid, Accelerated Phase | 21 |
| Leukemia, Myeloid, Chronic-Phase | 21 |
| Lymphoma, Non-Hodgkin | 21 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Blast Crisis | 20 |
| Lymphoma, B-Cell, Marginal Zone | 20 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.